Showing 3,621 - 3,640 results of 6,516 for search '"neurological"', query time: 0.10s Refine Results
  1. 3621

    Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway by Sichao Guo, Fengwu Li, Melissa Wills, James Yip, Alexandra Wehbe, Changya Peng, Xiaokun Geng, Yuchuan Ding

    Published 2022-01-01
    “…Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. …”
    Get full text
    Article
  2. 3622

    Risk Factors for Prolonged Length of Stay of Older Patients in an Academic Emergency Department: A Retrospective Cohort Study by Özcan Sir, Gijs Hesselink, Mara Van Den Bogaert, Reinier P. Akkermans, Yvonne Schoon

    Published 2019-01-01
    “…Risk factors for prolonged LOS of older patients at the ED were follows: higher number (more than one) of consultations (OR [odds ratio] 2.4, CI [confidence interval] 2.0-2.91), or diagnostic interventions (OR 1.5, CI 1.4-1.7); presenting complaints of a neurological (OR 2.2, CI 1.0-4.5) or internal medicine focus (OR 2.6, CI 1.4-4.6); patients with an altered consciousness (OR 3.3, CI 1.6-6.6); treatment by physicians of the departments of surgery (OR 3.4, CI 2.2-5.2), internal medicine (OR 2.6, CI 1.9-3.7), or pulmonology (OR 2.2, CI 1.4-3.6); and urgency category of ≥ U1. …”
    Get full text
    Article
  3. 3623

    Association of hypertension and plant-based dietary patterns on cognitive impairment: a nationwide cohort study in China by Fang Liang, Jialin Fu, Gabrielle Turner-McGrievy, Yechuang Wang, Kai Ding, Jing Zeng, Justin B Moore, Rui Li

    Published 2024-11-01
    “…Adherence to healthful PBD pattern could be used to prevent or mitigate adverse neurological effects in the hypertensive population.…”
    Get full text
    Article
  4. 3624

    Impact of gender on the prognosis of carotid body tumor after surgical resection by Huanrui Hu, Yuwei Xiang, Bin Huang, Ding Yuan, Yi Yang, Jichun Zhao

    Published 2021-09-01
    “…Although tumor size and Shamblin classification had positive relationships with neurological complications and intraoperative blood loss, they did not affect the overall survival rate of patients, which was only influenced by remote metastasis (P = .007) and local recurrence (P = .008). …”
    Get full text
    Article
  5. 3625

    From pain to meningitis: bacteria hijack nociceptors to promote meningitis by Huazhen Liu, Xingxing Kong, Yuqin Zeng, Jinyun Chen, Zhanpeng Chen, Lanlan Liu, Quan Ma, Xuhui Liu, Xuhui Liu, Shuihua Lu

    Published 2025-01-01
    “…This condition carries a high risk of mortality and severe neurological sequelae, such as cognitive impairment and epilepsy. …”
    Get full text
    Article
  6. 3626

    Genetic and molecular mechanisms of hydrocephalus by Xuehai Deng, Xuehai Deng, Yiqian Chen, Yiqian Chen, Qiyue Duan, Qiyue Duan, Jianlin Ding, Jianlin Ding, Zhong Wang, Zhong Wang, Junchi Wang, Xinlong Chen, Liangxue Zhou, Long Zhao

    Published 2025-01-01
    “…Hydrocephalus is a neurological condition caused by aberrant circulation and/or obstructed cerebrospinal fluid (CSF) flow after cerebral ventricle abnormal dilatation. …”
    Get full text
    Article
  7. 3627

    Characterization of Stroke Patients in an Intensive Care Unit by Marianela Planes Fajardo, Georgia Díaz-Perera Fernández, Maylín Isabel Alonso Martínez, Aurora Calzada Fajardo

    Published 2021-06-01
    “…Stroke is the main neurological cause of death and the third most common cause of death in the world. …”
    Get full text
    Article
  8. 3628
  9. 3629

    Rare Manifestation of a c.290 C>T, p.Gly97Glu VCP Mutation by Nivedita U. Jerath, Cameron D. Crockett, Steven A. Moore, Michael E. Shy, Conrad C. Weihl, Tsui-Fen Chou, Tiffany Grider, Michael A. Gonzalez, Stephan Zuchner, Andrea Swenson

    Published 2015-01-01
    “…Our patient reflects the clinical heterogeneity of VCP mutations, as his neurological localization is a spectrum between a lower motor neuron disorder and a hereditary axonal peripheral neuropathy such as CMT2. …”
    Get full text
    Article
  10. 3630

    Case report of neurobrucellosis: a rare complication and neuroimaging findings of a common disease by Yu Zhang, Yu Zhang, Xiao-Yi Zou, Xiao-Yi Zou, Ling Liu

    Published 2025-01-01
    “…Background and objectiveNeurobrucellosis is a rare neurological disorder characterized by diverse clinical manifestations. …”
    Get full text
    Article
  11. 3631

    Comorbidity in in patients with relapsing-remitting multiple sclerosis by O.V. Somilo, S.O. Makarov, O.I. Kalbus

    Published 2024-10-01
    “…All patients were assessed using the Multiple Sclerosis Neurological Disability Severity Scale (EDSS). Study participants were divided into two groups – Group 1 and Group 2 – based on EDSS scores. …”
    Get full text
    Article
  12. 3632

    The role of isoniazid dosage and NAT2 gene polymorphism in the treatment of tuberculous meningitis by Yi Jian, Yuhang Bao, Fashuang Yang, Mei Zhu

    Published 2025-01-01
    “…Univariate analysis showed significant differences between groups in baseline focal neurological impairment and disability or mortality by the 3rd and 12th months. …”
    Get full text
    Article
  13. 3633

    The role of olfactory transport in the penetration of manganese oxide nanoparticles from blood into the brain by A. V. Romashchenko, M. B. Sharapova, К. N. Morozova, E. V. Kiseleva, K. E. Kuper, D. V. Petrovskii

    Published 2019-07-01
    “…The accumulation of NPs in CNS can provoke many neurological diseases; therefore, the understanding of its mechanisms is of both academic and practical interest. …”
    Get full text
    Article
  14. 3634
  15. 3635

    The functional instrumental test of flexion-extension motion in the radiocarpal joint: reference parameters by Dmitry V. Skvortsov, Danila A. Lobunko, Galina Е. Ivanova

    Published 2024-12-01
    “…The research sample was a group of 15 healthy volunteers (5 males and 10 females aged from 23 to 33 years), not having any joint diseases or neurological disorders. The research was carried out within a period of one year (2022–2023). …”
    Get full text
    Article
  16. 3636

    Dystonia caused by ANO3 variants is due to attenuated Ca2+ influx by ORAI1 by Jiraporn Ousingsawat, Khaoula Talbi, Hilario Gómez-Martín, Anne Koy, Alberto Fernández-Jaén, Hasan Tekgül, Esra Serdaroğlu, Juan Darío Ortigoza-Escobar, Rainer Schreiber, Karl Kunzelmann

    Published 2025-01-01
    “…Abstract Background Dystonia is a common neurological hyperkinetic movement disorder that can be caused by mutations in anoctamin 3 (ANO3, TMEM16C), a phospholipid scramblase and ion channel. …”
    Get full text
    Article
  17. 3637

    The potential of stem cell therapy in Multiple Sclerosis treatment: a review by Sorina Amarculesei, Ava O'Meara Cushen, Cathy Brougham

    Published 2023-12-01
    “…There are currently 371 clinical trials involving mesenchymal stem cells and 462 clinical trials involving adipose derived stem cells, with research focused on skeletal applications, wound healing, and to a lesser degree, haematological and neurological disorders. Although adipose derived stem cells could represent a valuable treatment option for many diseases, several drawbacks to their advancement remain, such as their pro-tumorigenic properties, possible negative alteration of the immune system, and the difficulty in assessing their migration patterns once administered in vivo. …”
    Get full text
    Article
  18. 3638

    Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis? by Marie-Lise Gougeon, Valérie Seffer, Cezarela Hoxha, Elisabeth Maillart, Michel R. Popoff

    Published 2025-01-01
    “…Multiple sclerosis (MS) is a chronic immune-mediated neurological disorder, characterized by progressive demyelination and neuronal cell loss in the central nervous system. …”
    Get full text
    Article
  19. 3639

    Diagnostic Validation for Participants in the Washington State Parkinson Disease Registry by Hojoong M. Kim, James B. Leverenz, Daniel J. Burdick, Sindhu Srivatsal, Jennifer Pate, Shu-Ching Hu, Steven P. Millard, Marie Y. Davis, Ali Samii, Cyrus P. Zabetian

    Published 2018-01-01
    “…Those who responded were invited to undergo an interview and neurological examination performed by a PD specialist. …”
    Get full text
    Article
  20. 3640

    Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency by Maximiliano Presa, Rachel M. Bailey, Somdatta Ray, Lauren Bailey, Saurabh Tata, Tara Murphy, Pierre-Alexandre Piec, Harold Combs, Steven J. Gray, Cathleen Lutz

    Published 2025-01-01
    “…Abstract Background Multiple Sulfatase Deficiency (MSD) is a rare inherited lysosomal storage disorder characterized by loss of function mutations in the SUMF1 gene that manifests as a severe pediatric neurological disease. There are no available targeted therapies for MSD. …”
    Get full text
    Article